Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis
about
Role of prostaglandins in neuroinflammatory and neurodegenerative diseasesCOX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.Inflammation in ALS and SMA: sorting out the good from the evil.Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1.COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia.Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis.Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Motor neuron-immune interactions: the vicious circle of ALS.Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis.Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms.Therapeutic targets in prostaglandin E2 signaling for neurologic disease.Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy.The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.ALS and oxidative stress: the neurovascular scenarioThe executioners sing a new song: killer caspases activate microglia.Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes.Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS.Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation.Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.
P2860
Q26863534-EE5EC413-5F5B-4357-9C77-5C8647D839BDQ33235278-6BECAB5D-FA0B-4DCF-B907-F93A8C999E90Q33664711-C5741E79-2D0D-403E-9CDD-730E3A1525DEQ33723622-95744536-961A-4293-9C08-57EE57B86A78Q34732834-24B24C7F-E1F5-4121-B6A3-9DD85DAD5F8FQ35274780-3B8F0D6C-3F8C-40B1-8BB6-8E596B8343A3Q35615166-8EF335B9-5D92-4373-91FA-47AE93D282D4Q35903755-3FD5DED4-F7B2-44FA-A14F-1119AE27A7D7Q36048230-4684E28E-75FC-4CB0-80FD-64B3C0C32F41Q36067379-9D0B1EF2-4A22-4858-8538-D74D6C7F41C8Q36437332-ACF9E622-C38B-4E9D-B539-42DAB0FFD95FQ36565656-B24D315E-0200-4BD4-B312-3E0CF938DE08Q36811555-6B2E63E2-C541-4FFF-9DF8-3A1D0404384DQ37221356-4EC464B1-8D02-4CCF-B07A-E62D766B34AAQ37312724-C3AE0C30-677C-47CD-9B77-053EC601E8DEQ37397946-072370E9-2114-48D8-8691-8331909A3669Q37400451-8C1FFB78-8F01-4DA4-9E84-932A185C2173Q37916221-4EE4D98B-A29C-4F5A-963C-D2AFEFE7F4D7Q37959310-0A9A8142-453C-462E-B267-D90B0BB030B8Q37981224-FE6AA470-A8CB-4CE5-9AB7-699D80E0CF7CQ40394491-C8440D3E-D2E7-4650-A778-85974C248C2EQ45220851-0E7C12EC-658E-432D-A48E-91AD8DB1CB3AQ46416699-7607FFDB-15BC-428A-A0F4-059A8B0C86A3Q46836622-E4941C9D-6FBE-4E81-A78F-AFE1994AF55CQ48547293-8DBD94F1-7B61-416D-BABC-0F3FE21DED89
P2860
Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression and localization of ...... amyotrophic lateral sclerosis
@ast
Expression and localization of ...... amyotrophic lateral sclerosis
@en
Expression and localization of ...... amyotrophic lateral sclerosis
@en-gb
Expression and localization of ...... amyotrophic lateral sclerosis
@nl
type
label
Expression and localization of ...... amyotrophic lateral sclerosis
@ast
Expression and localization of ...... amyotrophic lateral sclerosis
@en
Expression and localization of ...... amyotrophic lateral sclerosis
@en-gb
Expression and localization of ...... amyotrophic lateral sclerosis
@nl
prefLabel
Expression and localization of ...... amyotrophic lateral sclerosis
@ast
Expression and localization of ...... amyotrophic lateral sclerosis
@en
Expression and localization of ...... amyotrophic lateral sclerosis
@en-gb
Expression and localization of ...... amyotrophic lateral sclerosis
@nl
P2093
P2860
P921
P3181
P1476
Expression and localization of ...... amyotrophic lateral sclerosis
@en
P2093
Bernhard Neundörfer
Christian Maihöfner
Dieter Heuss
Markus Bergmann
Stefan Probst-Cousin
Winfried Neuhuber
P2860
P304
P3181
P356
10.1046/J.1460-9568.2003.02879.X
P407
P577
2003-09-01T00:00:00Z